Sanara MedTech, Inc. (SMTI)
34.34
-0.11
(-0.32%)
USD |
NASDAQ |
Aug 24, 16:00
34.34
0.00 (0.00%)
After-Hours: 20:00
Sanara MedTech Enterprise Value : 349.81M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 349.81M |
| August 20, 2026 | 347.88M |
| August 19, 2026 | 348.25M |
| August 18, 2026 | 347.24M |
| August 17, 2026 | 345.68M |
| August 14, 2026 | 347.05M |
| August 13, 2026 | 347.15M |
| August 12, 2026 | 348.71M |
| August 11, 2026 | 349.17M |
| August 10, 2026 | 347.97M |
| August 07, 2026 | 346.59M |
| August 06, 2026 | 346.50M |
| August 05, 2026 | 346.32M |
| August 04, 2026 | 346.23M |
| August 03, 2026 | 345.68M |
| July 31, 2026 | 344.39M |
| July 30, 2026 | 346.23M |
| July 29, 2026 | 311.20M |
| July 28, 2026 | 278.01M |
| July 27, 2026 | 270.75M |
| July 24, 2026 | 268.08M |
| July 23, 2026 | 267.53M |
| July 22, 2026 | 267.90M |
| July 21, 2026 | 267.53M |
| July 20, 2026 | 262.93M |
| Date | Value |
|---|---|
| July 17, 2026 | 262.93M |
| July 16, 2026 | 265.88M |
| July 15, 2026 | 258.57M |
| July 14, 2026 | 248.68M |
| July 13, 2026 | 262.20M |
| July 10, 2026 | 252.09M |
| July 09, 2026 | 252.64M |
| July 08, 2026 | 255.86M |
| July 07, 2026 | 261.00M |
| July 06, 2026 | 264.50M |
| July 02, 2026 | 261.46M |
| July 01, 2026 | 256.22M |
| June 30, 2026 | 249.97M |
| June 29, 2026 | 260.04M |
| June 26, 2026 | 253.62M |
| June 25, 2026 | 246.66M |
| June 24, 2026 | 244.55M |
| June 23, 2026 | 234.10M |
| June 22, 2026 | 234.10M |
| June 18, 2026 | 236.58M |
| June 17, 2026 | 229.24M |
| June 16, 2026 | 242.72M |
| June 15, 2026 | 235.34M |
| June 12, 2026 | 225.49M |
| June 11, 2026 | 231.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intelligent Bio Solutions, Inc. | 4.90M |
| Anteris Technologies Global Corp. | 620.97M |
| 20/20 Biolabs, Inc. | 4.356M |
| Quest Diagnostics, Inc. | 33.02B |
| Labcorp Holdings, Inc. | 33.85B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.4111M |
| Revenue (Quarterly) | 28.14M |
| Total Expenses (Quarterly) | 28.55M |
| EPS Diluted (Quarterly) | -0.0523 |
| Gross Profit Margin (Quarterly) | 90.76% |
| Profit Margin (Quarterly) | -1.46% |
| Earnings Yield | -10.80% |
| Operating Earnings Yield | 3.82% |
| Normalized Earnings Yield | -10.09 |